| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c3082ea21b9dc6e81f0425279c19ee7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-088 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-088 |
| filingDate |
1990-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b369197fad5be46bc5940982f50e1689 |
| publicationDate |
1990-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0385491-A1 |
| titleOfInvention |
Optically active isomer of cloperastine possessing antitussive activity, a process for its preparation and pharmaceutical compositions which contain it |
| abstract |
The present invention relates to the optical isomers of cloperastine, a compound of formula:n Because of the presence of the asymmetric carbon atom marked with the asterisk, the compound (I) exists in its dextrorotatory and levorotatory isomer forms. n The invention provides a process for the optical resolution of raceme DL-cloperastine and pharmaceutical compositions containing L-cloperastine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104327014-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100458560-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103601701-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102336723-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102336723-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104529943-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019004953-A1 |
| priorityDate |
1989-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |